Home › Funds › Jones Hill Capital LP › BMRN

Jones Hill Capital LP position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Jones Hill Capital LP reported holding 1,171,859 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$70.3M, representing 11.93% of its reported portfolio and ranking #1 among its reported holdings. Jones Hill Capital LP has disclosed BMRN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.17M sh
Reported value held$70.31M
Portfolio Weight11.93%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's BMRN position evolved

Jones Hill Capital LP first disclosed a stake in BMRN in Q1 2026 at 1,268,390 shares (US$71.7M). The position peaked in Q2 2026 at 1,431,590 shares, worth US$81.9M. Across 3 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,171,859 shares valued at US$70.3M — a reduction of -259,731 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.27M $71.65M New
Q2 2026 1.43M $81.92M Add
Q3 2026 1.17M $70.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Jones Hill Capital LP held BMRN?

Jones Hill Capital LP has disclosed BMRN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Jones Hill Capital LP's current position in BMRN?

As of Q3 2026, Jones Hill Capital LP holds 1.17M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $70.31M, representing 11.93% of its reported portfolio and ranking #1.

Has Jones Hill Capital LP been buying or selling BMRN?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP reduced its position in BMRN. The position peaked in Q2 2026 at 1.43M shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.